Invention in the REGENERATIVE MEDICINE is what we do every day, benefits of patients is our final goal

Our Products

Home > Products

Cata #: Name of Product: Price:
HRP-2836 Recombinant Human UBE2C Protein $200
img

Recombinant Human UBE2C Protein

Product Name: Recombinant Human UBE2C Protein
Catalog #:  HRP-2836
Manufacture:  LD Biopharma, Inc.
Introduction:

Human Ubiquitin-Conjugating Enzyme E2 C (UBE2C) gene encodes a E2 enzyme which accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro, it catalyzes 'Lys-11'- and 'Lys-48'-linked polyubiquitination. UBE2C acts as an essential factor of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated ubiquitin ligase that controls progression through mitosis. UBE2C acts by initiating 'Lys-11'-linked polyubiquitin chains on APC/C substrates, leading to the degradation of APC/C substrates by the proteasome and promoting mitotic exit. 


Full-length human UBE2C cDNA (178aa, derived from BC016292) was constructed with codon optimization gene synthesis and expressed with a human N-terminalT7-His-TEV cleavage site Tag (31aa) fusion. This protein was expressed in E. coli as soluble one. The final product was purified using affinity column.

Gene Symbol:  

UBE2C ( UBCH10 )

 
Accession Number:  NP_008950
Species:  Human
Package Size:  25 µg / Vial   
Composition: 0.5 mg/ml, sterile-filtered, in 20% Glycerol / PBS buffer.
Storage: In Liquid. Keep at -80°C for long term storage. Product is stable at 4 °C for at least two weeks.
Key Reference:

Rape M.,, et al.,Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry. Nature. Dec 2;432(7017):588-95.(2004) doi: 10.1038/nature03023. Epub 2004 Nov 21.

Jiang,Y., et al.,UBE2C regulates the KEAP1/NRF2 signaling pathway to promote the growth of gastric cancer by inhibiting autophagy. Int J Biol Macromol 276 (Pt 2), 134011 (2024)


Li,W.,et al.,UBE2C-induced crosstalk between mono- and polyubiquitination ofSNAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest 134 (13), e179122 (2024)

Applications:
  1. May be used for in vitro UBE2JC mediated E3 pathway regulation for various cells study using intracellular delivery of recombinant human UBE2JC protein with protein delivery reagent such as ProFectin. 
  2. May be used for UBE2JC protein-protein interaction assay.
  3. May be used as specific E2 protein for ubiquitin related enzyme functional screening assays. 
  4. Potential therapeutic protein, which may be used for modulating cancer cell rapid cell-dividing cycle for cancer prevention or treatment. 
  5. As native human UBE2JC immunogen for specific antibody production.
Quality Control: Purity: > 92 % by SDS-PAGE.
Recombinant Protein Sequence:

MASMTGGQQMGRGHHHHHHENLYFQGGEFASQNRDPAATSVAAARKGAEPSGGAARGPVGKRLQQELMTLMMSGDKGISAFPESDNLFKWVGTIHGAAGTVYEDLRYKLSLEFPSGYPYNAPTVKFLTPCYHPNVDTQGNICLDILKEKWSALYDVRTILLSIQSLLGEPNIDSPLNTHAAELWKNPTAFKKYLQETYSKQVTSQEP

Download Datasheet